Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 14

1.

Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ( 18F-FAZA).

Postema EJ, McEwan AJ, Riauka TA, Kumar P, Richmond DA, Abrams DN, Wiebe LI.

Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1565-73. doi: 10.1007/s00259-009-1154-5. Epub 2009 May 9.

PMID:
19430784
2.

Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study.

Souvatzoglou M, Grosu AL, Röper B, Krause BJ, Beck R, Reischl G, Picchio M, Machulla HJ, Wester HJ, Piert M.

Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1566-75. Epub 2007 Apr 20.

PMID:
17447061
3.

Chemotherapy in the primary treatment of cervical carcinoma.

Serkies K, Jassem J.

Crit Rev Oncol Hematol. 2005 Jun;54(3):197-208. Review.

PMID:
15890269
4.

Hypoxia and anemia: effects on tumor biology and treatment resistance.

Vaupel P, Mayer A.

Transfus Clin Biol. 2005 Feb;12(1):5-10. Review.

PMID:
15814285
5.

Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation.

Reischl G, Ehrlichmann W, Bieg C, Solbach C, Kumar P, Wiebe LI, Machulla HJ.

Appl Radiat Isot. 2005 Jun;62(6):897-901.

PMID:
15799867
6.

Imaging hypoxia and angiogenesis in tumors.

Rajendran JG, Krohn KA.

Radiol Clin North Am. 2005 Jan;43(1):169-87. Review.

PMID:
15693655
7.

Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

Piert M, Machulla HJ, Picchio M, Reischl G, Ziegler S, Kumar P, Wester HJ, Beck R, McEwan AJ, Wiebe LI, Schwaiger M.

J Nucl Med. 2005 Jan;46(1):106-13.

8.

Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response.

Vaupel P, Harrison L.

Oncologist. 2004;9 Suppl 5:4-9. Review.

9.

Functional imaging of intratumoral hypoxia.

Foo SS, Abbott DF, Lawrentschuk N, Scott AM.

Mol Imaging Biol. 2004 Sep-Oct;6(5):291-305. Review.

PMID:
15380739
10.

[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.

Sorger D, Patt M, Kumar P, Wiebe LI, Barthel H, Seese A, Dannenberg C, Tannapfel A, Kluge R, Sabri O.

Nucl Med Biol. 2003 Apr;30(3):317-26.

PMID:
12745023
11.

Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.

Dehdashti F, Grigsby PW, Mintun MA, Lewis JS, Siegel BA, Welch MJ.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1233-8.

PMID:
12654432
12.

Measuring Tumor Hypoxia.

Raleigh JA, Dewhirst MW, Thrall DE.

Semin Radiat Oncol. 1996 Jan;6(1):37-45.

PMID:
10717160
13.
14.

Hypoxic sensitizers--implications for radiation therapy.

Chapman JD.

N Engl J Med. 1979 Dec 27;301(26):1429-32. Review. No abstract available.

PMID:
229413

Supplemental Content

Support Center